- UroToday Home
- Urologic Oncology
Prostate Cancer Abstracts and Beyond
Recent Abstracts
-
Tumor architecture and emergence of strong genetic alterations are bottlenecks for clonal evolution in primary prostate cancer.Prostate CancerNovember 25, 2024
-
Using a behaviour-change approach to support uptake of population genomic screening and management options for breast or prostate cancer.Prostate CancerNovember 25, 2024
-
Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer.Prostate CancerNovember 25, 2024
-
PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects.Prostate CancerNovember 25, 2024
-
Organ-confined prostate cancer with negative surgical margins in an entirely-embedded radical prostatectomy is essentially non-lethal-a retrospective single-institutional study of 520 patients.Prostate CancerNovember 25, 2024
-
Association of Race and Area of Deprivation Index with Prostate Cancer Incidence and Lethality.Prostate CancerNovember 25, 2024
-
Central Nervous System Toxicity in Prostate Cancer Patients Treated with Androgen Receptor Signaling Inhibitors: A Systematic Review, Meta-analysis, and Network Meta-analysis.Prostate CancerNovember 25, 2024
-
Cost-effectiveness analysis of additional local prostate radio therapy in metastatic prostate cancer from a medicare perspective.Prostate CancerNovember 25, 2024
-
Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapy.Prostate CancerNovember 22, 2024
-
Projected Outcomes of Reduced-Biopsy Management of Grade Group 1 Prostate Cancer: Implications for Relabeling.Prostate CancerNovember 22, 2024
Beyond the Abstracts
-
CDK12 Loss Drives Prostate Cancer Progression, Transcription-Replication Conflicts, and Synthetic Lethality with Paralog CDK13 - Beyond the AbstractProstate CancerNovember 21, 2024
-
Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data - Beyond the AbstractProstate CancerNovember 19, 2024
-
Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma - Beyond the AbstractProstate CancerNovember 18, 2024
-
Preclinical and Clinical Evidence for Using Perinatal Tissue Allografts in Nerve Sparing Robot Assisted Radical Prostatectomy to Hasten Recovery of Functional Outcomes: A Literature Review - Beyond the AbstractProstate CancerNovember 14, 2024
-
PSMA PET Improves Characterization of Dural-Based Intracranial Lesions in Patients with Metastatic Prostate Cancer - Beyond the AbstractProstate CancerNovember 7, 2024
-
Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival - Beyond the AbstractProstate CancerNovember 6, 2024
-
Testosterone Therapy in Men after Radical Prostatectomy for Organ-Confined, Low-Intermediate Prostate Cancer - Beyond the AbstractProstate CancerNovember 5, 2024
-
Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-Analysis with Bayesian Modeling of Treatment Histories - Beyond the AbstractProstate CancerNovember 5, 2024
-
First-Line Combination Treatment with PARP and Androgen Receptor-Signaling Inhibitors in HRR-Deficient mCRPC: Applying Clinical Study Findings to Clinical Practice in the United States - Beyond the AbstractProstate CancerNovember 5, 2024
-
A Phase I Trial of Image-Guided, Risk-Volume-Adapted Post-Prostatectomy Radiotherapy - Beyond the AbstractProstate CancerOctober 31, 2024